An Overview of Existing and Emerging Weight-Loss Drugs to Target Obesity-Related Complications: Insights from Clinical Trials. [PDF]
Kim MK, Kim HS.
europepmc +1 more source
Metabolic advances in 2025: from clinical breakthroughs to molecular reprogramming. [PDF]
Dalamaga M, Liu J.
europepmc +1 more source
Pharmacological therapies for type 2 diabetes: future approaches. [PDF]
Bailey CJ.
europepmc +1 more source
Incretin polyagonists as an alternative to bariatric surgery to manage obesity. [PDF]
Manoj RJ +3 more
europepmc +1 more source
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. [PDF]
Renke G, Chinellato L.
europepmc +1 more source
Gut-Brain Hormone Analogues and Metabolic Magic Wand. [PDF]
Jacob JJ.
europepmc +1 more source
The 40% weight-reduction craze: market volatility, metabolic nuance, and the quest for sustainable health. [PDF]
Han W +6 more
europepmc +1 more source
CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum. [PDF]
Schnell O +51 more
europepmc +1 more source
GLP-1RA- and Incretin-Based Therapies Within Lifestyle Interventions for Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis. [PDF]
Bruna-Mejias A +7 more
europepmc +1 more source

